|
Published by: Medtech Insight
Published: Jan. 1, 2009 - 439 Pages
Table of Contents
- EXECUTIVE SUMMARY
- i. European Market for Oral Drug Delivery Products
- a. Diffusion-Controlled Systems
- b. Solvent-Activated Systems
- c. Chemically Controlled Systems
- d. Regulated Systems
- e. Closed-Loop Systems
- f. Multiparticulate Systems
- g. Technological Advances
- h. Market Analysis
- ii. European Market for Transdermal Drug Delivery Products
- a. Single-Layer Drug-in-Adhesive
- b. Multilayer Drug-in-Adhesive
- c. Reservoir
- d. Matrix
- e. Technological Advances
- f. Market Analysis
- iii. European Market for Inhalation Drug Delivery Products
- a. Metered Dose Inhalers
- b. Dry Powder Inhalers
- c. Nebulizer Inhalers
- d. Liquid-Based Inhalers
- e. Technological Advances
- f. Market Analysis
- iv. European Market for Transmucosal Drug Delivery Products
- a. Buccal/Sublingual
- b. Nasal
- c. Ocular
- d. Vaginal
- e. Market Analysis
- v. European Market for Injectable Drug Delivery Products
- a. Injection Drug Delivery Products
- b. Infusion Drug Delivery Products
- c. Market Analysis
- vi. Combined Market Analysis
- Exhibit ES-1: Europe, Oral Drug Delivery Products, Market Forecast, by Country, 2007-2013 ES-8
- Exhibit ES-2: Europe, Transdermal Drug Delivery Systems, Market Forecast, by Country, 2007-2013
- Exhibit ES-3: Europe, Inhalation Drug Delivery Products, Market Forecast, by Country, 2007-2013
- Exhibit ES-4: Europe, Transmucosal Drug Delivery Products, Market Forecast, by Country, 2007-2013
- Exhibit ES-5: Europe, Injectable Drug Delivery Products, Market Forecast, by Country, 2007-2013
- Exhibit ES-6: Europe, Sales of Drug Delivery Products, by Market Segment, 2007 and 2013
- Exhibit ES-7: Europe, Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013
- 1. EUROPEAN HEALTHCARE MARKETS
- 1.1 The European Union
- 1.1.1 A Common Currency
- 1.1.2 Regulatory Policies
- 1.1.3 Reimbursement
- 1.1.4 Healthcare Spending
- 1.2 Selected European National Healthcare Profiles
- 1.2.1 France
- 1.2.1.1 Healthcare Organization and Reform
- 1.2.1.2 Hospital Services
- 1.2.1.3 Medical Device Reimbursement
- 1.2.2 Germany
- 1.2.2.1 Healthcare Organization and Reform
- 1.2.2.2 Hospital Services
- 1.2.2.3 Medical Device Reimbursement
- 1.2.3 Italy
- 1.2.3.1 Healthcare Organization and Reform
- 1.2.3.2 Hospital Services
- 1.2.3.3 Medical Device Reimbursement
- 1.2.4 Spain
- 1.2.4.1 Healthcare Organization and Reform
- 1.2.4.2 Hospital Services
- 1.2.4.3 Medical Device Reimbursement
- 1.2.5 United Kingdom
- 1.2.5.1 Healthcare Organization and Reform
- 1.2.5.2 Hospital Services
- 1.2.5.3 Medical Device Reimbursement
- 1.2.6 Benelux
- 1.2.6.1 Healthcare Organization and Reform
- 1.2.6.1.1 Belgium
- 1.2.6.1.2 Luxembourg
- 1.2.6.1.3 The Netherlands
- 1.2.6.2 Hospital Services
- 1.2.6.3 Medical Device Reimbursement
- 1.2.7 Nordic Countries
- 1.2.7.1 Healthcare Organization and Reform
- 1.2.7.1.1 Denmark
- 1.2.7.1.2 Finland
- 1.2.7.1.3 Norway
- 1.2.7.1.4 Sweden
- 1.2.7.2 Hospital Services
- 1.2.7.3 Medical Device Reimbursement
- Exhibit 1-1: European Union, Medical Devices Risk Classification System
- Exhibit 1-2: European Union Population Statistics Comparison for the Years 1996, 2006, and 2016
- Exhibit 1-3: France, Selected National Healthcare Statistics
- Exhibit 1-4: Germany, Selected National Healthcare Statistics
- Exhibit 1-5: Italy, Selected National Healthcare Statistics
- Exhibit 1-6: Spain, Selected National Healthcare Statistics
- Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics
- Exhibit 1-8: Belgium, Selected National Healthcare Statistics
- Exhibit 1-9: Luxembourg, Selected National Healthcare Statistics
- Exhibit 1-10: The Netherlands, Selected National Healthcare Statistics
- Exhibit 1-11: Denmark, Selected National Healthcare Statistics
- Exhibit 1-12: Finland, Selected National Healthcare Statistics
- Exhibit 1-13: Norway, Selected National Healthcare Statistics
- Exhibit 1-14: Sweden, Selected National Healthcare Statistics
- 2. OVERVIEW OF DRUG DELIVERY
- 2.1 Current Developments
- 2.2 Pharmacokinetics
- 2.2.1 Drug Absorption
- 2.2.1.1 Transportation Across Cell Membranes
- 2.2.1.1.1 Active Transport
- 2.2.1.1.2 Facilitated Passive Diffusion
- 2.2.1.1.3 Passive Diffusion
- 2.2.1.1.4 Pinocytosis
- 2.2.1.2 Oral Drug Delivery
- 2.2.1.3 Parenteral Drug Delivery
- 2.2.1.4 Transdermal Drug Delivery
- 2.2.1.5 Inhalation Drug Delivery
- 2.2.2 Drug Distribution
- 2.2.3 Drug Metabolism
- 2.2.3.1 Enzyme Induction
- 2.2.3.2 Enzyme Inhibition
- 2.2.3.3 Factors Affecting Metabolism
- 2.2.4 Drug Elimination
- 2.2.4.1 Metabolism
- 2.2.4.2 Excretion
- 2.3 Pharmacodynamics
- 2.3.1 Agonists and Antagonists
- Exhibit 2-1: Relationship Between Pharmacokinetics and Pharmacodynamics
- Exhibit 2-2: Routes for Parenteral Drug Delivery
- Exhibit 2-3: Advantages and Disadvantages of Transdermal Drug Delivery
- Exhibit 2-4: Biochemical Pathway for Oxidative Drug Metabolism
- Exhibit 2-5: Examples of Physiologic and Drug-Receptor Proteins
- 3. EUROPEAN MARKET FOR ORAL DRUG DELIVERY PRODUCTS
- 3.1 Controlled-Release Oral Drug Delivery Systems
- 3.1.1 Diffusion-Controlled Systems
- 3.1.1.1 Reservoir Systems
- 3.1.1.2 Monolithic Systems
- 3.1.2 Solvent-Activated Systems
- 3.1.2.1 Hydrophilic Matrix Tablets
- 3.1.2.2 Osmotically Controlled Systems
- 3.1.3 Chemically Controlled Systems
- 3.1.3.1 Biodegradable Systems
- 3.1.3.2 Covalent Polymer-Drug Conjugate Systems
- 3.1.4 Regulated Systems
- 3.1.4.1 Magnetically Controlled Systems
- 3.1.4.2 Ultrasound-Controlled Systems
- 3.1.4.3 Orally Disintegrating Systems
- 3.1.5 Closed-Loop Systems
- 3.1.6 Multiparticulate Systems
- 3.1.7 Advances in Oral Drug Delivery Technologies
- 3.1.7.1 Prodrugs
- 3.1.7.2 Pulsatile Systems
- 3.1.7.3 Liposomes
- 3.2 Products and Technologies
- 3.3 Market Analysis
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
- 3.3.3 Market Forecast
- 3.3.4 Competitive Analysis
- Exhibit 3-1: Advantages and Disadvantages of Controlled-Release Oral Drug Delivery Products
- Exhibit 3-2: Reservoir-Based Diffusion-Controlled Drug Delivery
- Exhibit 3-3: Advantages and Disadvantages of Reservoir-Based Diffusion-Controlled Drug Delivery Systems
- Exhibit 3-4: Monolithic Diffusion-Controlled Drug Delivery
- Exhibit 3-5: 2008, Selected Polymers Used in Matrix/Coating Oral Drug Delivery Products
- Exhibit 3-6: OROS Osmotic Technology
- Exhibit 3-7: Advantages of Osmotic Drug Delivery Systems
- Exhibit 3-8: Ultrasound-Controlled Drug Delivery
- Exhibit 3-9: Advantages of Orally Disintegrating Drug Delivery Systems
- Exhibit 3-10: 2008, Selected Orally Disintegrating Drug Delivery Systems
- Exhibit 3-11: Advantages and Disadvantages of Multiparticulate Drug Delivery Systems
- Exhibit 3-12: 2008, Selected Types of Pulsatile Drug Delivery Systems
- Exhibit 3-13: 2008, Selected Oral Drug Delivery Systems
- Exhibit 3-14: Europe, Oral Drug Delivery Products, Market Forecast, by Country, 2007-2013
- Exhibit 3-15: 2007, Europe, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-16: 2007, France, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-17: 2007, Germany, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-18: 2007, Italy, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-19: 2007, Spain, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-20: 2007, United Kingdom, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-21: 2007, Benelux Countries, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-22: 2007, Nordic Countries, Oral Drug Delivery Products Market, Share by Supplier
- Exhibit 3-23: 2007, Rest of Europe, Oral Drug Delivery Products Market, Share by Supplier
- 4. EUROPEAN MARKET FOR TRANSDERMAL DRUG DELIVERY PRODUCTS
- 4.1 Anatomy and Physiology of the Skin
- 4.2 Types of Transdermal Drug Delivery Systems
- 4.2.1 Single-Layer Drug-in-Adhesive
- 4.2.2 Multilayer Drug-in-Adhesive
- 4.2.3 Reservoir
- 4.2.4 Matrix
- 4.2.5 Basic Components of Transdermal Drug Delivery Systems
- 4.2.5.1 Backing Films
- 4.2.5.2 Release Liners
- 4.2.5.3 Pressure-Sensitive Adhesives
- 4.2.5.4 Active Ingredient(s)
- 4.2.5.5 Penetration Enhancers
- 4.2.5.6 Semipermeable Membranes
- 4.2.5.7 Pouching Materials
- 4.3 Technological Advances
- 4.3.1 Chemical Permeation Enhancers
- 4.3.2 Physical Permeation Enhancers
- 4.3.2.1 Electrical Methods
- 4.3.2.1.1 Electroporation
- 4.3.2.1.2 Iontophoresis
- 4.3.2.2 Mechanical Methods
- 4.3.2.2.1 Abrasion
- 4.3.2.2.2 Microneedle Puncture
- 4.3.2.2.3 Needleless Injection
- 4.3.2.3 Other Methods
- 4.3.2.3.1 Laser and Photomechanical Waves
- 4.3.2.3.2 Magnetophoresis
- 4.3.2.3.3 Noninvasive Radiofrequency-Enhanced Drug Delivery
- 4.3.2.3.4 Sonophoresis
- 4.3.2.3.5 Thermal-Assisted Transdermal Drug Delivery
- 4.4 Products and Technologies
- 4.5 Market Analysis
- 4.5.1 Market Drivers
- 4.5.2 Market Limiters
- 4.5.3 Market Forecast
- 4.5.4 Competitive Analysis
- Exhibit 4-1: Advantages and Disadvantages of Transdermal Drug Delivery
- Exhibit 4-2: Anatomy of the Skin
- Exhibit 4-3: Single-Layer Drug-in-Adhesive Transdermal Drug Delivery
- Exhibit 4-4: Multilayer Drug-in-Adhesive Transdermal Drug Delivery
- Exhibit 4-5: Reservoir Transdermal Drug Delivery
- Exhibit 4-6: Matrix Transdermal Drug Delivery
- Exhibit 4-7: Advantages and Disadvantages of Pressure-Sensitive Adhesives Used in Transdermal Drug Delivery Systems
- Exhibit 4-8: Classification of Physical Permeation Enhancement Methods
- Exhibit 4-9: Electroporation Enhancement of Transdermal Drug Delivery
- Exhibit 4-10: Iontophoresis Enhancement of Transdermal Drug Delivery
- Exhibit 4-11: Microneedle Delivery Devices for Transdermal Drug Delivery
- Exhibit 4-12: PowderMed’s Needleless Particle-Mediated Epidermal Delivery Device
- Exhibit 4-13: Ultrasound-Enhanced Transdermal Drug Delivery
- Exhibit 4-14: 2009, Selected Transdermal Drug Delivery Systems
- Exhibit 4-15: 2007, Europe, Sales of Transdermal Drug Delivery Systems, by Segment
- Exhibit 4-16: Europe, Transdermal Drug Delivery Systems, Market Forecast, by Country, 2007-2013
- Exhibit 4-17: 2007, Europe, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-18: 2007, France, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-19: 2007, Germany, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-20: 2007, Italy, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-21: 2007, Spain, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-22: 2007, United Kingdom, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-23: 2007, Benelux Countries, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-24: 2007, Nordic Countries, Transdermal Drug Delivery Systems Market, Share by Supplier
- Exhibit 4-25: 2007, Rest of Europe, Transdermal Drug Delivery Systems Market, Share by Supplier
- 5. EUROPEAN MARKET FOR INHALATION DRUG DELIVERY PRODUCTS
- 5.1 Anatomy and Physiology of the Respiratory System
- 5.2 Physiochemical Principles in Inhalation Drug Delivery
- 5.3 Types of Inhalation Drug Delivery Systems
- 5.3.1 Metered Dose Inhalers
- 5.3.2 Dry Powder Inhalers
- 5.3.3 Nebulizer Inhalers
- 5.3.4 Liquid-Based Inhalers
- 5.3.5 Emerging Developments
- 5.3.5.1 Inhaled Gene Therapy
- 5.3.5.2 Inhaled Liposomes
- 5.3.5.3 Inhaled Systemic Drugs
- 5.3.5.4 Inhaled Vaccines
- 5.3.5.5 Piezo-Electronic Inhalers
- 5.4 Formulation Components
- 5.4.1 Metered Dose Inhaler Formulation Components
- 5.4.1.1 Solution Formulations
- 5.4.1.2 Suspension Propellant Formulations
- 5.4.2 Dry Powder Inhaler Formulation Components
- 5.4.2.1 Adhesive Mixture Formulations
- 5.4.2.2 Soft Spherical Pellet Formulations
- 5.5 Products and Technologies
- 5.6 Market Analysis
- 5.6.1 Market Drivers
- 5.6.2 Market Limiters
- 5.6.3 Market Forecast, Metered Dose Inhalers
- 5.6.3.1 Competitive Analysis
- 5.6.4 Market Forecast, Dry Powder Inhalers
- 5.6.4.1 Competitive Analysis
- 5.6.5 Market Forecast, Nebulizer Inhalers
- 5.6.5.1 Competitive Analysis
- 5.6.6 Market Forecast, Liquid-Based Inhalers
- 5.6.6.1 Competitive Analysis
- 5.6.7 Combined Market Forecast
- 5.6.7.1 Combined Competitive Analysis
- Exhibit 5-1: Evolution of Pulmonary Drug Delivery Devices
- Exhibit 5-2: Advantages of Pulmonary Drug Delivery
- Exhibit 5-3: Simple Diagram of the Lung Structure
- Exhibit 5-4: The Physiology of Gas Exchange
- Exhibit 5-5: Advantages and Disadvantages of Pressurized Metered Dose Inhalers
- Exhibit 5-6: Mechanism of a Pressurized Metered Dose Inhaler
- Exhibit 5-7: Advantages and Disadvantages of Dry Powder Inhalers
- Exhibit 5-8: Advantages and Disadvantages of Nebulizer Inhalers
- Exhibit 5-9: Piezo-Electronic Inhaler Technology
- Exhibit 5-10: 2009, Selected Metered Dose Inhalers
- Exhibit 5-11: 2009, Selected Dry Powder Inhalers
- Exhibit 5-12: 2009, Selected Nebulizer Inhalers
- Exhibit 5-13: 2009, Selected Liquid-Based Inhalers
- Exhibit 5-14: Europe, Metered Dose Inhalers, Market Forecast, by Country, 2007-2013
- Exhibit 5-15: 2007, Europe, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-16: 2007, France, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-17: 2007, Germany, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-18: 2007, Italy, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-19: 2007, Spain, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-20: 2007, United Kingdom, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-21: 2007, Benelux Countries, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-22: 2007, Nordic Countries, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-23: 2007, Rest of Europe, Metered Dose Inhalers Market, Share by Supplier
- Exhibit 5-24: Europe, Dry Powder Inhalers, Market Forecast, by Country, 2007-2013
- Exhibit 5-25: 2007, Europe, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-26: 2007, France, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-27: 2007, Germany, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-28: 2007, Italy, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-29: 2007, Spain, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-30: 2007, United Kingdom, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-31: 2007, Benelux Countries, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-32: 2007, Nordic Countries, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-33: 2007, Rest of Europe, Dry Powder Inhalers Market, Share by Supplier
- Exhibit 5-34: Europe, Nebulizer Inhalers, Market Forecast, by Country, 2007-2013
- Exhibit 5-35: 2007, Europe, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-36: 2007, France, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-37: 2007, Germany, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-38: 2007, Italy, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-39: 2007, Spain, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-40: 2007, United Kingdom, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-41: 2007, Benelux Countries, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-42: 2007, Nordic Countries, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-43: 2007, Rest of Europe, Nebulizer Inhalers Market, Share by Supplier
- Exhibit 5-44: Europe, Liquid-Based Inhalers, Market Forecast, by Country, 2007-2013
- Exhibit 5-45: 2007, Europe, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-46: 2007, France, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-47: 2007, Germany, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-48: 2007, Italy, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-49: 2007, Spain, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-50: 2007, United Kingdom, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-51: 2007, Benelux Countries, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-52: 2007, Nordic Countries, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-53: 2007, Rest of Europe, Liquid-Based Inhalers Market, Share by Supplier
- Exhibit 5-54: Europe, Sales of Inhalation Drug Delivery Products, by Market Segment, 2007 and 2013
- Exhibit 5-55: Europe, Inhalation Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013
- Exhibit 5-56: 2007, Europe, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-57: 2007, France, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-58: 2007, Germany, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-59: 2007, Italy, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-60: 2007, Spain, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-61: 2007, United Kingdom, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-62: 2007, Benelux Countries, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-63: 2007, Nordic Countries, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- Exhibit 5-64: 2007, Rest of Europe, Combined Inhalation Drug Delivery Products Market, Share by Supplier
- 6. EUROPEAN MARKET FOR TRANSMUCOSAL DRUG DELIVERY PRODUCTS
- 6.1 Types
- 6.1.1 Buccal and Sublingual Drug Delivery
- 6.1.2 Nasal Drug Delivery
- 6.1.3 Ocular Drug Delivery
- 6.1.3.1 Liquids
- 6.1.3.2 Solids
- 6.1.3.3 Semisolids
- 6.1.3.4 Other
- 6.1.4 Vaginal Drug Delivery
- 6.2 Products and Technologies
- 6.3 Market Analysis
- 6.3.1 Market Drivers
- 6.3.2 Market Limiters
- 6.3.3 Market Forecast
- 6.3.4 Competitive Analysis
- Exhibit 6-1: Advantages and Disadvantages of Nasal Drug Delivery
- Exhibit 6-2: Advantages of Ocular Insert Drug Delivery
- Exhibit 6-3: Advantages of Vaginal Drug Delivery
- Exhibit 6-4: 2008, Selected Nasal Drug Delivery Products
- Exhibit 6-5: 2008, Selected Buccal and Sublingual Drug Delivery Products
- Exhibit 6-6: 2008, Selected Ocular Drug Delivery Products
- Exhibit 6-7: 2008, Selected Vaginal Drug Delivery Products
- Exhibit 6-8: Europe, Transmucosal Drug Delivery Products, Market Forecast, by Country, 2007-2013
- Exhibit 6-9: 2007, Europe, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-10: 2007, France, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-11: 2007, Germany, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-12: 2007, Italy, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-13: 2007, Spain, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-14: 2007, United Kingdom, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-15: 2007, Benelux Countries, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-16: 2007, Nordic Countries, Transmucosal Drug Delivery Products Market, Share by Supplier
- Exhibit 6-17: 2007, Rest of Europe, Transmucosal Drug Delivery Products Market, Share by Supplier
- 7. EUROPEAN MARKET FOR INJECTABLE DRUG DELIVERY PRODUCTS
- 7.1 Types of Injection Drug Delivery
- 7.1.1 Intramuscular Injection
- 7.1.2 Subcutaneous Injection
- 7.1.3 Classification of Injection Devices
- 7.2 Types of Infusion Drug Delivery
- 7.2.1 Intraoperative Site Infusion
- 7.2.2 Intraspinal Infusion
- 7.2.3 Intravenous Infusion
- 7.2.4 External Infusion Pumps
- 7.2.4.1 Gravity-Controlled Pumps
- 7.2.4.2 Positive Displacement Pumps
- 7.2.4.2.1 Volumetric Infusion Pumps
- 7.2.4.2.2 Syringe Infusion Pumps
- 7.2.4.2.3 Patient-Controlled Analgesia Infusion Pumps
- 7.2.4.2.4 Ambulatory Pumps
- 7.2.4.2.5 Disposable Infusion Pumps
- 7.2.5 Implantable Infusion Pumps
- 7.3 Injection Drug Delivery, Products and Technologies
- 7.4 Infusion Drug Delivery, Products and Technologies
- 7.5 Market Analysis
- 7.5.1 Market Drivers
- 7.5.2 Market Limiters
- 7.5.3 Market Forecast, Injection Drug Delivery Devices
- 7.5.3.1 Competitive Analysis
- 7.5.4 Market Forecast, Infusion Drug Delivery Products
- 7.5.4.1 Competitive Analysis
- 7.5.5 Combined Market Forecast
- 7.5.5.1 Combined Competitive Analysis
- Exhibit 7-1: Advantages and Disadvantages of Syringe Pumps
- Exhibit 7-2: Advantages and Disadvantages of Patient-Controlled Analgesia Infusion Pumps
- Exhibit 7-3: Advantages and Disadvantages of Disposable Infusion Pumps
- Exhibit 7-4: 2009, Selected Disposable Safety Syringes
- Exhibit 7-5: 2009, Selected Prefilled Syringes
- Exhibit 7-6: 2009, Selected Insulin Pen Injectors
- Exhibit 7-7: 2009, Selected Needle-Free Liquid Jet Injectors
- Exhibit 7-8: 2009, Selected Hypodermic Needles and Syringes
- Exhibit 7-9: 2009, Selected Insulin Infusion Pumps
- Exhibit 7-10: 2009, Selected Syringe Infusion Pumps
- Exhibit 7-11: 2009, Selected Volumetric Infusion Pumps
- Exhibit 7-12: 2009, Selected Patient-Controlled Analgesia Infusion Pumps
- Exhibit 7-13: 2009, Selected Ambulatory Infusion Pumps
- Exhibit 7-14: 2009, Selected Constant-Flow Implantable Infusion Pumps
- Exhibit 7-15: 2009, Selected Programmable Implantable Infusion Pumps
- Exhibit 7-16: Europe, Injection Drug Delivery Products, Market Forecast, by Country, 2007-2013
- Exhibit 7-17: 2007, Europe, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-18: 2007, France, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-19: 2007, Germany, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-20: 2007, Italy, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-21: 2007, Spain, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-22: 2007, United Kingdom, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-23: 2007, Benelux Countries, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-24: 2007, Nordic Countries, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-25: 2007, Rest of Europe, Injection Drug Delivery Products Market, Share by Supplier
- Exhibit 7-26: Europe, Infusion Drug Delivery Products, Market Forecast, by Country, 2007-2013
- Exhibit 7-27: 2007, Europe, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-28: 2007, France, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-29: 2007, Germany, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-30: 2007, Italy, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-31: 2007, Spain, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-32: 2007, United Kingdom, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-33: 2007, Benelux Countries, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-34: 2007, Nordic Countries, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-35: 2007, Rest of Europe, Infusion Drug Delivery Products Market, Share by Supplier
- Exhibit 7-36: Europe, Injectable Drug Delivery Products, Combined Market Forecast, by Country, 2007-2013
- Exhibit 7-37: 2007, Europe, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-38: 2007, France, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-39: 2007, Germany, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-40: 2007, Italy, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-41: 2007, Spain, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-42: 2007, United Kingdom, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-43: 2007, Benelux Countries, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-44: 2007, Nordic Countries, Combined Injectable Drug Delivery Products Market, Share by Supplier
- Exhibit 7-45: 2007, Rest of Europe, Combined Injectable Drug Delivery Products Market, Share by Supplier
- 8. COMPANY PROFILES
- 8.1 3M Health Care, Inc./3M Company
- 8.2 AstraZeneca PLC
- 8.3 Baxter International, Inc.
- 8.4 B. Braun Melsungen AG
- 8.5 Becton, Dickinson and Company
- 8.6 Biovail Corporation
- 8.7 Boehringer Ingelheim GmbH
- 8.8 Cardinal Health, Inc.
- 8.9 Elan Corporation PLC
- 8.10 Fresenius SE
- 8.11 GlaxoSmithKline PLC
- 8.12 Johnson & Johnson
- 8.13 Novartis AG
- 8.14 Noven Pharmaceuticals, Inc.
- 8.15 Terumo Europe NV/Terumo Corporation
- APPENDIX: COMPANY LISTING
AbstractPharmacotherapy represents the predominant first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in Europe. This report covers oral, transdermal, inhalation, transmucosal, and injectable drug delivery devices. In 2007, European sales of these products totaled approximately $25 billion; over the forecast period covered by this report, sales are expected to increase at a compound annual growth rate of 11.2%, reaching more than $47 billion in the year 2013.
This new report by Medtech Insight presents a detailed overview of the European drug delivery products and technologies market. Major topics covered by this report include an overview of European healthcare markets; an overview of the biomechanics of drug delivery; discussions of drug delivery devices in the oral, transdermal, inhalation, transmucosal, and injectable market segments; and analyses of each of the sales and leading competitors in each of these markets.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
